Litcius/Paper detail

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

Katie Hege-Hurrish, Yongwei Su, Shraddha Patel, Cassandra L. Ramage, Jianlei Zhao, Brianna R. Temby, Jenna L. Carter, Holly Edwards, Steven Buck, Sandra E. Wiley, Maik Hüttemann, Lisa Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Xun Bao, Jing Li, Jay Yang, Julie L. Boerner, Zhanjun Hou, Gheath Alatrash, Sergej Konoplev, Jonathan Busquets, Stefano Tiziani, Larry H. Matherly, Jeffrey W. Taub, Marina Konopleva, Yubin Ge, Natalia Baran

2023Biochemical Pharmacology18 citationsDOIOpen Access PDF

Topics & Concepts

CytarabineVenetoclaxMyeloid leukemiaVenPharmacologyLeukemiaCancer researchPurine analogueMedicineBiologyPurineImmunologyChronic lymphocytic leukemiaBiochemistryEnzymeComputer scienceComputer securityAcute Myeloid Leukemia ResearchHistone Deacetylase Inhibitors ResearchCancer therapeutics and mechanisms